157 related articles for article (PubMed ID: 9564119)
1. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting of patients with advanced cancer.
Mystakidou K; Befon S; Liossi C; Vlachos L
J Pain Symptom Manage; 1998 Mar; 15(3):176-84. PubMed ID: 9564119
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
Mystakidou K; Befon S; Liossi C; Vlachos L
Cancer; 1998 Sep; 83(6):1214-23. PubMed ID: 9740088
[TBL] [Abstract][Full Text] [Related]
3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
4. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
5. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
6. Tropisetron versus Metoclopramide in the Control of Emesis in Far-Advanced Cancer.
Mystakidou K; Befon S; Trifyllis J; Liossi C; Papadimitriou J
Oncologist; 1997; 2(5):319-323. PubMed ID: 10388064
[TBL] [Abstract][Full Text] [Related]
7. The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation.
Barbounis V; Koumakis G; Hatzichristou H; Vassilomanolakis M; Tsoussis S; Efremidis A
Support Care Cancer; 1999 Mar; 7(2):79-83. PubMed ID: 10089087
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.
Schmidt M; Sorbe B; Högberg T; Himmelmann A; Räisänen I; Stockmeyer M; de Bruijn KM
Ann Oncol; 1993; 4 Suppl 3():31-4. PubMed ID: 8363997
[TBL] [Abstract][Full Text] [Related]
9. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
Malik I; Moid I; Khan Z; Hussain M
Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
[TBL] [Abstract][Full Text] [Related]
11. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
Simpson K; Spencer CM; McClellan KJ
Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
[TBL] [Abstract][Full Text] [Related]
12. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
13. Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide.
Miralbell R; Coucke P; Behrouz F; Blazek N; Melliger M; Philipp S; Wickenhauser R; Gebhard S; Schwabb T; Rosset A
Eur J Cancer; 1995; 31A(9):1461-4. PubMed ID: 7577072
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery).
Vayne-Bossert P; Haywood A; Good P; Khan S; Rickett K; Hardy JR
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012002. PubMed ID: 28671265
[TBL] [Abstract][Full Text] [Related]
15. Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy: a randomized trial.
Adams M; Soukop M; Barley V; Yosef H; Anderson H; Boesen E; Trask CW; Rüfenacht E; de Bruijn KM
Anticancer Drugs; 1995 Aug; 6(4):514-21. PubMed ID: 7579555
[TBL] [Abstract][Full Text] [Related]
16. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
17. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
[TBL] [Abstract][Full Text] [Related]
18. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
19. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Aksoylar S; Akman SA; Ozgenç F; Kansoy S
Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
